2018
DOI: 10.1136/esmoopen-2018-eacr25.366
|View full text |Cite
|
Sign up to set email alerts
|

PO-336 ThruPLEX® and PicoPLEX® technologies for rare alleles and copy number variation detection from cell-free DNA and single human cancer cells

Abstract: IntroductionLiquid biopsies provide a non-invasive method to acquire the genetic information provided in cell-free DNA (cfDNA) as well as in single circulating tumour cells. Access to this genetic information through next-generation sequencing (NGS) identifies mutations and alterations such as Copy Number Variation (CNV) that play a role in cancer and other diseases.Material and methodsThe key to identifying rare mutations is improved sequencing accuracy and the ability to distinguish between biological and PC… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles